Effectiveness Study of Changing Immunosuppressive Drugs in Kidney and Liver Patients Who Have Developed Abnormal Glucose Levels
This study will examine the effectiveness of changing immunosuppressive drugs in patients who have had a kidney or liver transplant within the past six months and have developed abnormal glucose levels. Patients will be randomly assigned to either maintain their current medication regimen or change to the study drug. The study will last 26 weeks.
To be eligible, participants must:
This is a partial list of eligibility requirements.